Matthew Maxwell Donley, COO: Aurinia Pharmaceuticals AUPH Sell · Filed 25/03/04

Trade details

Type: Insider sale
Amount: $467,208.72
Shares · price: 58,991 sh · $7.92 a share
Held after: 680,465 sh
Stock: Aurinia Pharmaceuticals AUPH
Person: Matthew Maxwell DonleyCOO
Trade date: 25/03/04
Filed: 25/03/04
Days to filing: 0 days

Sold 8.0% of holdings

Share of holding sold: 8.0%

Aurinia Pharmaceuticals trades, last 26 weeks

What else happened in Aurinia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/02~25/04/03

Matthew Maxwell Donley's recent trades

Matthew Maxwell DonleyCOO
Planned saleAurinia Pharmaceuticals
Planned sale
Aurinia Pharmaceuticals
AUPH
$11.4M
717,688 sh
$11.4M
Filed 05/11
Traded 05/11
Matthew Maxwell DonleyCOO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$527.2K
65,902 sh
$527.2K
Filed 25/03/04
Traded 25/03/03
Matthew Maxwell DonleyEVP, Ops & Strategy
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$224.1K
40,665 sh
$224.1K
Filed 24/03/07
Traded 24/03/06

Matthew Maxwell Donley, COO — sold $467.2K of Aurinia Pharmaceuticals AUPH · 8.0% of holdings | Whalegun